| Literature DB >> 35052991 |
Moushumi Hazra1, Lisa M Durso2.
Abstract
Domestic and industrial wastewater discharges harbor rich bacterial communities, including both pathogenic and commensal organisms that are antibiotic-resistant (AR). AR pathogens pose a potential threat to human and animal health. In wastewater treatment plants (WWTP), bacteria encounter environments suitable for horizontal gene transfer, providing an opportunity for bacterial cells to acquire new antibiotic-resistant genes. With many entry points to environmental components, especially water and soil, WWTPs are considered a critical control point for antibiotic resistance. The primary and secondary units of conventional WWTPs are not designed for the reduction of resistant microbes. Constructed wetlands (CWs) are viable wastewater treatment options with the potential for mitigating AR bacteria, their genes, pathogens, and general pollutants. Encouraging performance for the removal of AR (2-4 logs) has highlighted the applicability of CW on fields. Their low cost of construction, operation and maintenance makes them well suited for applications across the globe, especially in developing and low-income countries. The present review highlights a better understanding of the performance efficiency of conventional treatment plants and CWs for the elimination/reduction of AR from wastewater. They are viable alternatives that can be used for secondary/tertiary treatment or effluent polishing in combination with WWTP or in a decentralized manner.Entities:
Keywords: antibiotic-resistant genes/bacteria; constructed wetlands; conventional treatment plants; macrophytes; treated effluent; wastewater
Year: 2022 PMID: 35052991 PMCID: PMC8773441 DOI: 10.3390/antibiotics11010114
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Figure 1Source, development, pathway and potential threats of ARB/ARGs on the environment, and application of constructed wetlands through various mechanisms for the reduction of the same (Note: ARGs—antibiotic resistant genes; ARB—antibiotic resistant bacteria; AB—antibiotics, EC—emerging contaminants).
Description of the question of concern for the present review study related to antibiotic resistance in wastewater and the use of constructed wetlands in reducing the loads from treated effluents.
| Q1. Protocols for AR | Q2. Treatment of WW, Sludge and Discharge of Effluents | Q3. Use of Natural Treatment System |
|---|---|---|
| What are the protocols/interventions implemented in India for the control of AR in the environment? | What are the technologies that assist in reducing the load of pollutants from wastewater? Are they able to reduce antibiotics, ARB and ARG load? | Are CWs efficient enough for the control of antibiotic resistance from the effluent of treatment plants? How effective is it, and can they be implemented at a larger scale? |
|
| ||
| National action plan on antimicrobial resistance (2017) | WW and sludge generated through urban sectors in both liquid and solid state or a mixture of both | Any water matrix contaminated through domestic and industrial wastewater, e.g., ponds, lakes, rivers, canals |
|
| ||
| Effective understanding of AMR through trainings, awareness and practice of health care in the community | Treatment of WW: primary, secondary and tertiary treatment through conventional methods in WWTP, as well as aerobic or anaerobic digestion | Use of NTS for efficient reduction of coliforms and AR from effluents of conventional treatment technologies [ |
|
| ||
| Veterinary and human uses, wastewater from domestic and industrial discharges, agricultural runoff | Treated effluents can be polished if CWs are coupled as tertiary units in WWTP [ | Disposal of treated effluent for multifarious uses such as reuse in toilets, aquaculture, gardening and agricultural purposes [ |
Note: AMR—antimicrobial resistance, AR—antibiotic resistance, ARB/ARG—antibiotic-resistant bacteria/antibiotic-resistant genes, CW—constructed wetlands, WWTP—wastewater treatment plants, NTS—natural treatment system.
Figure 2Removal of antibiotics, antibiotic-resistant bacteria and genes by conventional and tertiary treatment technology, including constructed wetlands (Note: VFCW-vertical flow CW, HFCW-horizontal flow CW, IFCW-integrated flow CW).
Figure 3Flow diagram representing, in brief, the protocols for antimicrobial resistance and benefits of using CWs in various organizations/institutes in India.
Removal efficiency of various CWs for reduction of ARB and resistant genes.
| Type of CW | Source/Type of Wastewater | Antibiotic-Resistant Bacteria/Antibiotic-Resistant Genes | Removal Efficiency | References |
|---|---|---|---|---|
| Hybrid/integrated flow CW | Mixed wastewater from restaurant, hostel & brewery | 99.5% | [ | |
| Dairy wastewater | Total coliforms, fecal coliforms, fecal streptococci, and | 99.93–99.99% | [ | |
| Raw domestic wastewater | 87.8% to 99.1% | [ | ||
| Domestic wastewater | Enterococci, | 84.0%, 66.6%, 67.2% & 13.1% | [ | |
| Raw landfill leachate | Sulfonamide resistance ( | >90% | [ | |
| Rural domestic wastewater | >99% | [ | ||
| Vertical flow CW | Urban wastewater | 46–97%, 33–97%, 9–99%, 18–97% & 11–98% | [ | |
| Swine wastewater | 95.1% | [ | ||
| Swine wastewater | Tetracycline-resistance genes ( | 33.2 to 99.1%, | [ | |
| Raw domestic wastewater | Sulfonamide resistance genes ( | 63.9 and 84.0% | [ | |
| Swine wastewater | Tetracycline resistance ( | Reduced by 50% | [ | |
| Horizontal flow CW | Raw domestic wastewater | 50.7–89.4%, 85.9–97%, 49.6–92.9%, 58.2–96.7% & 79.9–94.3% | [ | |
| Hospital wastewater | Tetracycline-, erythromycin- and ampicillin-resistant and higher multidrug-resistant bacteria | 80.8% to 93.2% | [ |